Clinical Trial Update: Study Evaluating Safety, Tolerability, and Immunogenicity of Meningococcal B Vaccine in Healthy Infants [Phase 2]

View source ↗

Summary

Pfizer conducted a Phase 2 study to evaluate the safety, tolerability, and immunogenicity of its Meningococcal B vaccine in healthy infants; the trial was termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Meningitis

Drugs mentioned

• Trumenba (rLP2086)

Snippet

Sponsor: Pfizer | Conditions: Meningitis, Meningococcal | Phase 2 | Status: TERMINATED | Results posted: 2014-11-26